Advancing Emerging Therapeutic Platforms with Chemistry-Led Development
Sai Life Sciences supports emerging therapeutic platforms through specialized capabilities in antibody–drug conjugates (ADCs), peptides, lipids, and oligonucleotides. Our teams integrate synthetic chemistry, analytical science, and process development to address the distinct design, synthesis, purification, and scale-up requirements of these modalities.
By aligning modality expertise with development and manufacturing readiness, we enable structured progression from discovery through early development within a scalable and regulatory-aligned framework.
Our Capabilities
The Sai Difference
New Modalities at Sai Life Sciences extend our chemistry-led development platform into advanced therapeutic classes while maintaining disciplined scale-up and regulatory alignment. We also bring together scientific depth, operational scalability, and an integrated chemistry-biology platform to advance emerging modalities efficiently.
Our combination of expertise and infrastructure enables reliable, development-ready outcomes.